Concepedia

Martin Hegen

MH

41

Publications

3.9K

Citations

33

H-Index

1990

Active since

Affiliations

Pfizer (United States)(Current)

Harvard University

Dana-Farber Cancer Institute

Johannes Gutenberg University Mainz

Martin Hegen is an author at Pfizer (United States) specializing in medicine, immunology, and pharmacology.

Top concepts

Publications per year

1990–2023

41

Publications

41

Parsing the Interferon Transcriptional Network and Its Disease Associations

Sara Mostafavi, Hideyuki Yoshida, Devapregasan Moodley et al. · Cell · 2016 · 336 citations

Blockade of the interleukin‐21/interleukin‐21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis

Deborah Young, Martin Hegen, Hak Ling Margery et al. · Arthritis & Rheumatism · 2007 · 271 citations

Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response

Runyu Dong, Junichi Kameoka, Martin Hegen et al. · The Journal of Immunology · 1996 · 213 citations · Full text

Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.

Jaya Krishnan, Vladimir Kirkin, Anja Steffen et al. · PubMed · 2003 · 188 citations

, , +17

Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition

Jean‐Baptiste Telliez, Martin E. Dowty, Lu Wang et al. · ACS Chemical Biology · 2016 · 187 citations · Full text

, , +30

Rows per page

1–5 of 41